DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS  
DIRECTOR'S OFFICE  
MEDICINE - GENERAL RULES  
(By authority conferred on the director of the department of licensing and regulatory  
affairs by sections 16145, 16148, 16174, 16204, 16215, 16287, 17031, 17033, 17048, and  
17076 of the public health code, 1978 PA 368, MCL 333.16145, 333.16148, 333.16174,  
333.16204, 333.16215, 333.16287, 333.17031, 333.17033, 333.17048, and 333.17076,  
and Executive Reorganization Order Nos. 1991-9, 1996-2, 2003-1, and 2011-4, MCL  
338.3501, 445.2001, 445.2011, and 445.2030)  
PART 1. GENERAL PROVISIONS  
R 338.2401 Definitions.  
Rule 101. (1) As used in these rules:  
(a) “Board” means the Michigan board of medicine created under section 17021 of the  
code, MCL 333.17021.  
(b) “Code” means the public health code, 1978 PA 368, MCL 333.1101 to 333.25211.  
(c) “Department” means the department of licensing and regulatory affairs.  
(2) A term defined in the code has the same meaning when used in these rules.  
History: 2016 AACS; 2021 MR 8, Eff. Apr. 26, 2021.  
R 338.2403 Rescinded.  
History: 2016 AACS; 2021 MR 8, Eff. Apr. 26, 2021.  
R 338.2405 Rescinded.  
History: 2016 AACS; 2021 MR 8, Eff. Apr. 26, 2021.  
R 338.2407 Telehealth.  
Rule 107. (1) Consent for treatment must be obtained before providing a telehealth  
service under section 16284 of the code, MCL 333.16284.  
(2) Proof of consent must be maintained in the patient’s up-to-date medical record and  
retained in compliance with section 16213 of the code, MCL 333.16213.  
(3) A physician providing a telehealth service may prescribe a drug if the physician is a  
prescriber acting within the scope of his or her practice and in compliance with section  
16285 of the code, MCL 333.16285, and if he or she does both of the following:  
Page 1  
(a) If medically necessary, refers the patient to a provider who is geographically  
accessible to the patient.  
(b) Makes himself or herself available to provide follow-up care services to the  
patient, or to refer the patient to another provider, for follow-up care.  
(4) A physician providing any telehealth service shall do both of the following:  
(a) Act within the scope of his or her practice.  
(b) Exercise the same standard of care applicable to a traditional, in-person health care  
service.  
History: 2021 MR 8, Eff. Apr. 26, 2021.  
R 338.2409 Prescribing of drugs by physician’s assistants; procedures and  
protocols.  
Rule 109. (1) Under sections 17048(2) and 17076(2) of the code, MCL 333.17048 and  
333.17076, and under the terms of a practice agreement, a physician’s assistant may  
prescribe a drug, including a controlled substance that is included in schedules 2 to 5 of  
part 72 of the code, MCL 333.7201 to 333.7231, subject to both of the following  
requirements:  
(a) If a physician's assistant prescribes a drug, the physician's assistant's name must be  
used, recorded, or otherwise indicated in connection with that prescription.  
(b) If a physician's assistant prescribes a drug that is included in schedules 2 to 5, the  
physician's assistant's Drug Enforcement Agency (DEA) registration number must be  
used, recorded, or otherwise indicated in connection with that prescription.  
(2) Under sections 17048(2) and 17076(3) of the code, MCL 333.17048 and 333.17076,  
and under the terms of a practice agreement, a physician's assistant may order, receive,  
and dispense complimentary starter dose drugs, including controlled substances that are  
included in schedules 2 to 5 of part 72 of the code, MCL 333.7201 to 333.7231, subject  
to both of the following requirements:  
(a) If a physician's assistant orders, receives, or dispenses a complimentary starter  
dose drug, the physician's assistant's name must be used, recorded, or otherwise indicated  
in connection with that order, receipt, or dispensing.  
(b) If a physician's assistant orders, receives, or dispenses a complimentary starter  
dose drug that is included in schedules 2 to 5, the physician's assistant's DEA registration  
number must be used, recorded, or otherwise indicated in connection with that order,  
receipt, or dispensing.  
History: 2016 AACS; 2021 MR 8, Eff. Apr. 26, 2021.  
R 338.2411 Delegation of prescribing controlled substances to an advanced practice  
registered nurse; limitation.  
Rule 111. (1) A physician may delegate the prescription of controlled substances listed  
in schedules 2 to 5 to a registered nurse who holds a specialty certification under section  
17210 of the code, MCL 333.17210, with the exception of a nurse anesthetist, if the  
delegating physician establishes a written authorization that contains all of the following  
information:  
Page 2  
(a) The name, license number, and signature of the delegating physician.  
(b) The name, license number, and signature of the nurse practitioner, nurse midwife,  
or clinical nurse specialist.  
(c) The limitations or exceptions to the delegation.  
(d) The effective date of the delegation.  
(2) The delegating physician shall review and update a written authorization on an  
annual basis from the original date or the date of amendment, if amended. The  
delegating physician shall note the review date on the written authorization.  
(3) The delegating physician shall maintain a written authorization at the delegating  
physician’s primary place of practice.  
(4) The delegating physician shall provide a copy of the signed, written authorization to  
the nurse practitioner, nurse midwife, or clinical nurse specialist.  
(5) The delegating physician shall ensure that an amendment to the written  
authorization is in compliance with subrules (1), (2), (3), and (4) of this rule.  
(6) A delegating physician may authorize a nurse practitioner, a nurse midwife, or a  
clinical nurse specialist to issue a multiple prescriptions allowing the patient to receive a  
total of up to a 90-day supply of a schedule 2 controlled substance.  
(7) A delegating physician shall not delegate the prescription of a drug or device  
individually, in combination, or in succession for a woman known to be pregnant with the  
intention of causing either a miscarriage or fetal death.  
History: 2016 AACS; 2021 MR 8, Eff. Apr. 26, 2021.  
R 338.2413 Training standards for identifying victims of human trafficking;  
requirements.  
Rule 113. (1) Under section 16148 of the code, MCL 333.16148, an individual seeking  
licensure or licensed shall complete training in identifying victims of human trafficking  
that satisfies the following standards:  
(a) Training content must cover all of the following:  
(i) Understanding the types and venues of human trafficking in this state or the  
United States.  
(ii) Identifying victims of human trafficking in health care settings.  
(iii) Identifying the warning signs of human trafficking in health care settings for  
adults and minors.  
(iv) Resources for reporting the suspected victims of human trafficking.  
(b) Acceptable providers or methods of training include any of the following:  
(i) Training offered by a nationally recognized or state-recognized, health-related  
organization.  
(ii) Training offered by, or in conjunction with, a state or federal agency.  
(iii) Training obtained in an educational program that has been approved by the  
board for initial licensure, or by a college or university.  
(iv) Reading an article related to the identification of victims of human trafficking  
that satisfies the requirements of subdivision (a) of this subrule and is published in a peer  
review journal, health care journal, or professional or scientific journal.  
(c) Acceptable modalities of training include any of the following:  
(i) Teleconference or webinar.  
Page 3  
(ii) Online presentation.  
(iii) Live presentation.  
(iv) Printed or electronic media.  
(2) The department may select and audit a sample of individuals and request  
documentation of proof of completion of training. If audited by the department, an  
individual shall provide an acceptable proof of completion of training, including either of  
the following:  
(a) Proof of completion certificate issued by the training provider that includes the  
date, provider name, name of training, and individual’s name.  
(b) A self-certification statement by an individual. The certification statement must  
include the individual’s name and either of the following:  
(i) For training completed under subrule (1)(b)(i) to (iii) of this rule, the date, training  
provider name, and name of training.  
(ii) For training completed under subrule (1)(b)(iv) of this rule, the title of article,  
author, publication name of peer review journal, health care journal, or professional or  
scientific journal, and date, volume, and issue of publication, as applicable.  
(3) Under section 16148 of the code, MCL 333.16148, the requirements specified in  
subrule (1) of this rule apply for license renewals beginning with the 2017 renewal cycle  
and for initial licensure beginning December 6, 2021.  
History: 2016 AACS; 2021 MR 8, Eff. Apr. 26, 2021.  
PART 2. LICENSES  
R 338.2421 Accreditation standards for approval of medical schools and medical  
residency programs.  
Rule 121. (1) The board approves and adopts by reference the standards for accrediting  
medical schools developed and adopted by the Liaison Committee on Medical Education,  
655 K Street, NW, Suite 100, Washington, District of Columbia 20001-2399, set forth in  
the publication entitled “Functions and Structures of a Medical School”, March 2018  
edition, which is available at no cost on the committee’s website at: www.lcme.org. The  
board considers any medical school accredited by the Liaison Committee on Medical  
Education approved by the board.  
(2) The board approves and adopts by reference the standards for approval of a  
postgraduate training program developed and adopted by the Accreditation Council for  
Graduate Medical Education, 401 N. Michigan Avenue, Suite 2000, Chicago, Illinois  
60611, effective July 1, 2016, and are available at no cost on the council’s website at:  
www.acgme.org. The board considers any medical postgraduate training program  
accredited by the Accreditation Council for Graduate Medical Education approved by the  
board.  
(3) The board approves and adopts by reference the standards for approval of a resident  
training program by the College of Family Physicians of Canada, 2630 Skymark Avenue,  
Mississauga, Ontario, Canada L4W 5A4, set forth in the publication entitled “Specific  
Standards for Family Medicine Training Programs Accredited by the College of Family  
Physicians of Canada,” 2016 edition available at no cost from the college’s website at:  
Page 4  
residency program accredited by the College of Family Physicians of Canada approved  
by the board.  
(4) The board approves and adopts by reference the standards for approval of a resident  
training program by the Royal College of Physicians and Surgeons of Canada, 774 Echo  
Drive, Ottawa, Ontario, Canada K1S 5N8 set forth in the publication entitled “General  
Standards of Accreditation,” June 2013 edition, available at no cost from the college’s  
website:  
The  
board  
considers any residency program accredited by the Royal College of Physicians and  
Surgeons approved by the board.  
(5) The board approves and adopts by reference the standards for approval of a resident  
training program by the Canadian Medical Association’s Conjoint Accreditation  
Services, 1867 Alta Vista Drive, Ottawa, Ontario, Canada K 1G 5W8, set forth in the  
publication entitled “Requirements for Accreditation,” 2014 edition, available at no cost  
from the association’s website at: http://www.cma.ca/learning/conjointaccreditation. The  
board considers any residency program accredited by the Conjoint Accreditation Service  
approved by the board.  
(6) Copies of the standards and criteria adopted by reference in subrules (1), (2), (3),  
(4), and (5) of this rule are available for inspection and distribution at a cost of 10 cents  
per page from the Board of Medicine, Bureau of Professional Licensing, Department of  
Licensing and Regulatory Affairs, 611 W. Ottawa, P.O. Box 30670, Lansing, Michigan  
48909.  
History: 2016 AACS; 2021 MR 8, Eff. Apr. 26, 2021.  
R 338.2423 Medical doctor; license requirements; United States and Canadian  
graduates.  
Rule 123. An applicant for a medical license who graduated from a medical school  
located inside the United States, its territories, or the Dominion of Canada, in addition to  
satisfying the requirements of the code, shall satisfy all of the following requirements:  
(a) Submit the required fee and a completed application on a form provided by the  
department.  
(b) Possess a degree from a medical school that satisfies the standards set forth in R  
338.2421(1).  
(c) Have passed all parts of the United States Medical Licensing Examination  
(USMLE) adopted under R 338.2431.  
(d) Have completed a minimum of 2 years of postgraduate clinical training in a  
program that satisfies the requirements of R 338.2421(2), (3), (4), or (5).  
(e) Submit a certificate of completion of the postgraduate training required under  
subdivision (d) of this rule to the department no more than 15 days prior to the scheduled  
date of completion.  
History: 2016 AACS; 2021 MR 8, Eff. Apr. 26, 2021.  
R 338.2425 Medical doctor; license requirements; foreign graduates.  
Page 5  
Rule 125. An applicant for a medical license who graduated from a medical school  
located outside the United States, its territories, or the Dominion of Canada, in addition to  
satisfying the requirements of the code, shall satisfy all of the following requirements:  
(a) Submit the required fee and a completed application on a form provided by the  
department.  
(b) Have certification provided directly to the department from the Educational  
Commission for Foreign Medical Graduates (ECFMG) verifying that the applicant has  
satisfied both of the following requirements:  
(i) Graduated from a medical school listed in the World Directory of Medical  
Schools.  
(ii) Passed all parts of the USMLE adopted under R 338.2431.  
(c) Completed a minimum of 2 years of postgraduate clinical training in a program  
that satisfies the requirements of R 338.2421(2), (3), (4), or (5).  
(d) Submit a certificate of completion of the postgraduate training required under  
subdivision (c) of this rule to the department no more than 15 days prior to the scheduled  
date of completion.  
History: 2016 AACS; 2021 MR 8, Eff. Apr. 26, 2021.  
R 338.2427 Licensure by endorsement.  
Rule 127. (1) An applicant for a Michigan medical license by endorsement shall  
submit the required fee and a completed application on a form provided by the  
department.  
(2) An applicant shall satisfy 1 of the following requirements:  
(a) Has first been licensed in good standing in another state and actively engaged in  
the practice of medicine for at least 10 years prior to the date of filing the application.  
(b) Has first been licensed in good standing in another state and actively engaged in  
the practice of medicine less than 10 years prior to the date of filing the application and  
satisfies both of the following requirements:  
(i) Passed all parts of the USMLE adopted under R 338.2431.  
(ii) Completed a minimum of 2 years of postgraduate clinical training in a program  
that satisfies the requirements of R 338.2421(2), (3), (4), or (5).  
(3) An applicant’s license shall be verified by the licensing agency of any state of the  
United States in which the applicant holds a current license or has ever held a license as a  
medical doctor. Verification includes, but is not limited to, showing proof that the  
applicant’s license is in good standing and, if applicable, any disciplinary action taken or  
pending against the applicant.  
History: 2016 AACS; 2021 MR 8, Eff. Apr. 26, 2021.  
R 338.2429 Educational limited license.  
Rule 129. (1) An individual not eligible for a Michigan medical license shall obtain an  
educational limited license before engaging in postgraduate training.  
Page 6  
(2) An applicant for an educational limited license who is from a medical school  
located inside the United States, its territories, or the Dominion of Canada, in addition to  
satisfying the requirements of the code, shall satisfy all of the following requirements:  
(a) Submit the required fee and a completed application on a form provided by the  
department.  
(b) Have documentation provided directly to the department from a medical school  
that satisfies the requirements of R 338.2421(1) verifying that the applicant has graduated  
or is expected to graduate within 3 months of the date of the application.  
(c) Have documentation provided directly to the department verifying that the  
applicant has been accepted into a postgraduate training program that satisfies the  
requirements of R 338.2421(2).  
(3) An applicant for an educational limited license who is from a medical school  
located outside the United States, its territories, or the Dominion of Canada, in addition to  
satisfying the requirements of the code, shall satisfy all of the following requirements:  
(a) Submit the required fee and a completed application on a form provided by the  
department.  
(b) Have certification provided directly from the ECFMG to the department verifying  
that the applicant has satisfied both of the following requirements:  
(i) Graduated from a medical school listed in the World Directory of Medical  
Schools.  
(ii) Passed parts 1 and 2 of the USMLE adopted under R 338.2431.  
(c) Have documentation provided directly to the department verifying that the  
applicant has been accepted into a postgraduate training program that satisfies the  
requirements of R 338.2421(2).  
(4) Under section 17012(2) of the code, MCL 333.17012, an educational limited license  
may be renewed not more than 5 years.  
History: 2016 AACS; 2021 MR 8, Eff. Apr. 26, 2021.  
R 338.2431 Examination; adoption; passing scores; limitation on attempts; time  
limitations.  
Rule 131. (1) The board adopts the United States Medical Licensing Examination  
(USMLE) developed and administered by the Federation of State Medical Boards  
(FSMB) which consists of the following parts:  
(a) USMLE – part 1.  
(b) USMLE – part 2.  
(c) USMLE – part 3.  
(2) The passing score for each part of the USMLE accepted for licensure is the passing  
score established by the FSMB.  
(3) An applicant shall not make more than 3 attempts to pass any part of the USMLE.  
(4) An applicant shall successfully pass all parts of the USMLE within 7 years from the  
date that he or she first passed any part of the USMLE. An applicant may request  
consideration of a variance of the 7-year requirement by providing, at a minimum, proof  
of both of the following requirements to the board:  
(a) That the applicant has already passed all parts of the USMLE, but that the time  
taken to pass all parts is more than 7 years.  
Page 7  
(b) That the applicant has completed either of the following activities:  
(i) Graduation from an accredited graduate degree program in addition to medical  
school.  
(ii) Completion of a residency or fellowship program with demonstrated consistent  
participation in the program.  
History: 2016 AACS; 2021 MR 8, Eff. Apr. 26, 2021.  
R 338.2433 Rescinded.  
History: 2016 AACS; 2021 MR 8, Eff. Apr. 26, 2021.  
R 338.2435 Clinical academic limited license.  
Rule 135. An applicant for a clinical academic limited license shall submit the required  
fee and a completed application on a form provided by the department. In addition to  
satisfying the requirements of the code, the applicant shall satisfy both of the following  
requirements:  
(a) Have documentation provided directly to the department verifying that he or she  
has been appointed to a position in an academic institution as defined in section  
17001(1)(a) of the code, MCL 333.17001.  
(b) Provide documentation from either of the following entities:  
(i) Verification provided directly to the department from a medical school that  
satisfies the requirements of R 338.2421(1), indicating that the applicant has graduated or  
is expected to graduate within 3 months of the date of the application.  
(ii) Certification provided directly to the department from the ECFMG indicating that  
the applicant has satisfied both of the following requirements:  
(A) Graduated from a medical school listed in the World Directory of Medical  
Schools.  
(B) Passed parts 1 and 2 of the USMLE adopted under R 338.2431.  
History: 2016 AACS; 2021 MR 8, Eff. Apr. 26, 2021.  
R 338.2437 Relicensure.  
Rule 137. (1) An applicant whose Michigan medical license has lapsed for less than 3  
years preceding the date of application for relicensure may be relicensed under section  
16201(3) of the code, MCL 333.16201, if the applicant satisfies all of the following  
requirements:  
(a) Submits the required fee and a completed application on a form provided by the  
department.  
(b) Submits proof to the department of completing not less than 150 hours of  
continuing education that satisfies the requirements of R 338.2443 during the 3 years  
immediately preceding the date of the application for relicensure.  
(c) Establishes that he or she is of good moral character as defined under 1974 PA  
381, MCL 338.41 to 338.47.  
Page 8  
(d) An applicant who holds or has ever held a license to practice medicine shall  
establish all of the following requirements:  
(i) Disciplinary proceedings are not pending against the applicant.  
(ii) If sanctions have been imposed against the applicant, the sanctions are not in  
force at the time of application.  
(iii) A previously held license was not surrendered or allowed to lapse to avoid  
discipline.  
(2) An applicant whose Michigan medical license has been lapsed for 3 years but less  
than 5 years may be relicensed under section 16201(4) of the code, MCL 333.16201, if  
the applicant submits fingerprints as set forth in section 16174(3) of the code, MCL  
333.16174, and satisfies the requirements of subrule (1) of this rule and either of the  
following requirements:  
(a) Presents proof to the department that he or she is actively licensed and in good  
standing as a medical doctor in another state.  
(b) Completes 1 of the following during the 3 years immediately preceding the date of  
the application for relicensure:  
(i) Takes and passes the Special Purpose Examination (SPEX) offered by the FSMB.  
The passing score is the passing score established by the FSMB.  
(ii) Successfully completes a postgraduate training program that satisfies the  
requirements of R 338.2421(2), (3), (4), or (5).  
(iii) Successfully completes a physician re-entry program accredited by the Coalition  
for Physician Enhancement (CPE).  
(iv) Successfully completes a physician re-entry program affiliated with a medical  
school that satisfies the requirements of R 338.2421(1).  
(3) An applicant whose Michigan medical license has been lapsed for 5 years or more  
may be relicensed under section 16201(4) of the code, MCL 333.16201, if the applicant  
submits fingerprints as set forth in section 16174(3) of the code, MCL 333.16174, and  
satisfies the requirements of subrule (1) of this rule and either of the following  
requirements:  
(a) Presents proof to the department that he or she is actively licensed and in good  
standing as a medical doctor in another state.  
(b) Completes both of the following during the 3 years immediately preceding the date  
of the application for relicensure:  
(i) Takes and passes the SPEX offered by the FSMB. The passing score is the  
passing score established by the FSMB.  
(ii) Successfully completes 1 of the following training options:  
(A) A postgraduate training program that satisfies the requirements of R  
338.2421(2), (3), (4), or (5).  
(B) A physician re-entry program that is accredited by the CPE.  
(C) A physician re-entry program affiliated with a medical school that satisfies the  
requirements of R 338.2421(1).  
(4) If required to complete the requirements of subrule (2)(b) or (3)(b) of this rule, the  
applicant may obtain an educational limited license for the sole purpose of completing  
that training.  
Page 9  
(5) An applicant with an educational limited license may be relicensed under section  
16201(3) or (4) of the code, MCL 333.16201(3) or (4), if he or she complies with subrule  
(1) of this rule and R 338.2429.  
(6) An applicant shall have his or her license verified by the licensing agency of any  
state of the United States in which the applicant holds or has ever held a license to  
practice as a medical doctor. Verification must include information that the license is in  
good standing and, if applicable, the record of any disciplinary action taken or pending  
against the applicant.  
History: 2016 AACS; 2021 MR 8, Eff. Apr. 26, 2021.  
PART 3. CONTINUING EDUCATION  
R 338.2441 License renewals.  
Rule 141. (1) This part applies to an application for renewal of a medical license under  
section 17031 of the code, MCL 333.17031, and a medical special volunteer license  
under section 16184 of the code, MCL 333.16184.  
(2) An applicant for license renewal who has been licensed in the 3-year period  
immediately preceding the application for renewal shall accumulate a minimum of 150  
hours of continuing education in activities approved by the board under R 338.2443  
during the 3 years immediately preceding the application for renewal.  
(3) Submission of an application for renewal constitutes the applicant’s certification of  
compliance with the requirements of this rule. The licensee shall retain documentation of  
satisfying the requirements of this rule for 4 years from the date of applying for license  
renewal. Failure to satisfy this rule is a violation of section 16221(h) of the code, MCL  
333.16221.  
(4) The department may select and audit a sample of licensees who have renewed their  
license and request proof of compliance with subrule (2) of this rule. If audited, a  
licensee shall submit documentation as specified in R 338.2443.  
History: 2016 AACS; 2021 MR 8, Eff. Apr. 26, 2021.  
R 338.2443 Acceptable continuing education; requirements; limitations.  
Rule 143. (1) The 150 hours of continuing education required under R 338.2441 must  
satisfy the following requirements, as applicable:  
(a) Credit for a continuing education program or activity that is identical or  
substantially identical to a program or activity for which the licensee has already earned  
credit during the renewal period cannot be granted.  
(b) A minimum of 1 hour of continuing education must be earned in the area of  
medical ethics.  
(c) For license renewals filed December 6, 2017, or later, a minimum of 3 hours of  
continuing education must be earned in the area of pain and symptom management under  
section 17033(2) of the code, MCL 333.17033(2). At least 1 of the 3 hours must include  
Page 10  
controlled substances prescribing. Continuing education hours in pain and symptom  
management may include, but are not limited to, any of the following areas:  
(i) Public health burden of pain.  
(ii) Ethics and health policy related to pain.  
(iii) Michigan pain and controlled substance laws.  
(iv) Pain definitions.  
(v) Basic sciences related to pain including pharmacology.  
(vi) Clinical sciences related to pain.  
(vii) Specific pain conditions.  
(viii) Clinical physician communication related to pain.  
(ix)  
Management of pain, including evaluation and treatment and non-  
pharmacological and pharmacological management.  
(x) Ensuring quality pain care and controlled substances prescribing.  
(xi) Michigan programs and resources relevant to pain.  
(d) A minimum of 75 continuing education credits must be obtained through category  
1 programs listed in subrule (2) of this rule.  
(2) The board considers any of the following activities as acceptable category 1  
continuing education:  
Activity and Proof of Completion  
Number of Continuing Education Hours  
granted/permitted for the activity  
(a) Attendance at or participation in a The number of continuing education  
continuing education program or hours for a specific program or activity is  
activity related to the practice of the number of hours approved by the  
medicine, which includes, but is not sponsor or the approving organization for  
limited to, live, in-person programs, the specific program. A maximum of  
interactive or monitored teleconference, 150 hours of continuing education may  
audio-conference,  
or  
web-based be earned for this activity during the  
programs, online programs, and journal renewal period.  
articles with a self-study component or  
other self-study programs approved or  
offered by any of the following  
organizations:  
American Medical Association  
Michigan State Medical Society  
Accreditation Council for Continuing  
Medical Education  
American Osteopathic Association  
Michigan Osteopathic Association  
If audited, the licensee must submit a  
copy of the letter or certificate of  
completion showing the licensee’s  
name, number of continuing education  
hours earned, sponsor name or the  
name of the organization that approved  
Page 11  
the program or activity for continuing  
education credit, and the date on which  
the program was held or the activity  
completed.  
(b) Taking and passing a specialty board A specialty board certification or  
certification  
or  
recertification recertification examination successfully  
examination for a specialty board passed during the renewal period is  
recognized by the American Board of granted 50 hours of continuing education  
Medical Specialties, the American credit. A maximum of 50 hours of  
Board of Physician Specialties, or the continuing education may be earned for  
National Board of Physicians and this activity in each renewal period.  
Surgeons.  
If audited, the licensee shall provide  
proof from the specialty board of the  
successful passing of the examination.  
(c) Successfully completing an activity that One hour of continuing education is  
is required for maintenance of a granted for every 60 minutes spent on the  
specialty certification for a board activity. A maximum of 30 hours may be  
recognized by the American Board of earned for this activity in each renewal  
Medical Specialties, the American period.  
Board of Physician Specialties, or the  
National Board of Physicians and  
Surgeons that does not satisfy the  
requirements of subrule 2(a) or 2(b) of  
this rule.  
If audited, the licensee shall provide  
proof from the specialty board that the  
activity was required for maintenance  
of certification, that the activity was  
successfully completed and the date of  
completion.  
(d) Participation in a clinical training Fifty hours of continuing education credit  
program that satisfies any of the per year may be granted for this activity.  
requirements of R 338.2421(2), (3), (4), A maximum of 150 hours of continuing  
or (5) or is accredited by a board education credit may be earned per  
recognized by the American Board of renewal period.  
Medical Specialties, the American  
Board of Physician Specialties, or the  
National Board of Physicians and  
Surgeons.  
To receive credit, the  
licensee shall be enrolled for a  
minimum of 5 months in a 12-month  
period.  
Page 12  
If audited, the licensee shall submit a  
letter from the program director  
verifying the licensee participated in  
the program.  
(3) The board considers any of the following activities as acceptable category 2  
continuing education:  
Activity and Proof of Completion  
Number of Continuing Education Hours  
granted/permitted for the activity  
(a) Serving as a clinical instructor for  
medical students or residents engaged  
Two hours of continuing education is  
granted for each 50 to 60 minutes of  
in a postgraduate training program that scheduled instruction. Additional credit  
satisfies requirements of R  
338.2421(2), (3), (4), or (5).  
for preparation of a lecture cannot be  
granted. A maximum of 48 hours of  
continuing education may be earned for  
this activity in each renewal period.  
To receive credit, the clinical  
instructorship must not be the  
licensee’s primary employment  
function.  
If audited, the licensee shall submit  
proof of scheduled instructional hours  
and a letter from the program director  
verifying the licensee’s role.  
(b) Initial presentation of a scientific  
exhibit, poster, or paper to a  
Two hours of continuing education is  
granted for each presentation. No  
additional credit is granted for  
professional medical organization.  
preparation of the presentation. A  
maximum of 24 hours of continuing  
education may be earned in this activity  
in each renewal period. Under R  
If audited, the licensee shall submit a  
copy of the document presented with  
proof of presentation or a letter from  
the program sponsor verifying the date 338.2443(1)(a), credit for a presentation  
of the presentation.  
(c) Publication of a scientific article  
is granted only once per renewal period.  
Six hours of continuing education is  
relating to the practice of medicine in a granted for serving as the primary author.  
peer-reviewed journal or periodical.  
Three hours of continuing education is  
granted for serving as a secondary author.  
A maximum of 24 hours of continuing  
education may be earned for this activity  
in each renewal period. Under R  
If audited, the licensee shall submit a  
copy of the publication that identifies  
the licensee as the author or a  
publication acceptance letter and  
documentation of the peer-review  
process.  
338.2443(1)(a), credit for an article is  
granted once per renewal period.  
(d) Initial publication of a chapter or a  
portion of a chapter related to the  
practice of medicine in either of the  
following textbooks:  
Five hours of continuing education is  
granted for serving as the primary author.  
Two hours of continuing education is  
granted for serving as a secondary author.  
Page 13  
A maximum of 24 hours of continuing  
education may be earned for this activity  
in each renewal period. Under R  
338.2443(1)(a), credit for publication is  
granted once per renewal period.  
A professional health care  
textbook.  
A peer-reviewed textbook.  
If audited, the licensee shall submit a  
copy of the publication that identifies  
the licensee as the author or a  
publication acceptance letter.  
(e) Participating on any of the following  
committees:  
Eighteen hours of continuing education is  
granted for participating on a committee.  
A maximum of 18 hours of continuing  
education may be earned for this activity  
in each renewal period.  
A peer review committee  
dealing with quality of patient  
care as it relates to the practice  
of medicine.  
A committee dealing with  
utilization review as it relates to  
the practice of medicine.  
A health care organization  
committee dealing with patient  
care issues related to the  
practice of medicine.  
A national or state committee,  
board, council, or association  
related to the practice of  
medicine.  
Participation in a committee, board,  
council, or association is considered  
acceptable by the board if it enhances  
the participant’s knowledge and  
understanding of the field of medicine.  
If audited, the licensee shall submit a  
letter from an organization official  
verifying the licensee’s participation in  
at least 50% of the regularly scheduled  
meetings of the committee, board,  
council, or association.  
(f) Until December 6, 2019, attendance at  
or participation in a continuing  
The number of continuing education  
hours for a specific program or activity is  
the number of hours approved by the  
board. A maximum of 36 hours of  
continuing education may be earned for  
this activity.  
education activity that had been  
approved by the board prior to the  
effective date of this rule but does not  
satisfy the requirements of subrule  
(2)(a) of this rule.  
If audited, the licensee shall submit a  
Page 14  
copy of the letter or certificate of  
completion showing the licensee’s  
name, number of continuing education  
hours earned, sponsor name or the  
name of the organization that approved  
the program or activity for continuing  
education credit, and the date on which  
the program was held or the activity  
was completed.  
(g) Independently reading a peer-reviewed Two hours of continuing education credit  
journal that does not satisfy the  
requirements of subrule (2)(a) of this  
rule. The reading must have been  
completed prior to the effective date of  
this rule.  
is granted for each article read. A  
maximum of 18 hours of continuing  
education may be earned for this activity.  
If audited, a licensee shall submit a  
bibliography listing the journal, article,  
authors, publication date, and date read.  
(h) Prior to December 6, 2016, completing The number of continuing education  
a multi-media self-assessment program hours is the number of hours approved by  
that does not satisfy the requirements of the activity sponsor. A maximum of 18  
subrule (2)(a) of this rule. The self-  
assessment program must improve the  
licensee’s knowledge and  
hours of continuing education credit may  
be earned for this activity.  
understanding of the practice of  
medicine.  
If audited, the licensee shall submit a  
certificate of self-assessment provided  
by the program sponsor.  
History: 2016 AACS; 2021 MR 8, Eff. Apr. 26, 2021.  
Page 15